Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,622,000 | 7,882,000 | 5,687,000 | 5,309,000 | 5,953,000 |
| Depreciation Amortization | 6,471,000 | 2,017,000 | 1,765,000 | 1,501,000 | 1,189,000 |
| Income taxes - deferred | -2,325,000 | 122,000 | -1,517,000 | 1,242,000 | N/A |
| Accounts receivable | -929,000 | -74,000 | -591,000 | -391,000 | -71,000 |
| Accounts payable and accrued liabilities | 1,514,000 | 97,000 | 734,000 | 425,000 | -1,187,000 |
| Other Working Capital | 969,000 | -1,408,000 | 467,000 | 93,000 | -1,299,000 |
| Other Operating Activity | 7,266,000 | 4,688,000 | 6,882,000 | 1,781,000 | 2,456,000 |
| Operating Cash Flow | $17,588,000 | $13,324,000 | $13,427,000 | $9,960,000 | $7,041,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -798,000 | -552,000 | -638,000 | -529,000 | -479,000 |
| Net Acquisitions | -39,610,000 | -1,135,000 | -736,000 | -308,000 | -2,757,000 |
| Purchase Of Investment | -61,000 | -583,000 | -1,792,000 | -2,230,000 | -5,315,000 |
| Sale Of Investment | 1,525,000 | 2,699,000 | 2,160,000 | 2,793,000 | 2,359,000 |
| Other Investing Activity | 1,387,000 | 167,000 | 0 | 0 | 118,000 |
| Investing Cash Flow | $-37,557,000 | $596,000 | $-1,006,000 | $-274,000 | $-6,074,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -699,000 | 3,301,000 | 23,000 | -23,000 |
| Debt Issued | 3,000,000 | 31,482,000 | 5,963,000 | 0 | 11,627,000 |
| Debt Repayment | -5,683,000 | -1,536,000 | -6,035,000 | -25,000 | -6,010,000 |
| Common Stock Issued | 209,000 | 8,000 | 73,000 | 254,000 | 268,000 |
| Common Stock Repurchased | -978,000 | -629,000 | -12,014,000 | -1,410,000 | -6,033,000 |
| Dividend Paid | -7,716,000 | -6,366,000 | -5,580,000 | -4,107,000 | -3,717,000 |
| Other Financing Activity | -333,000 | -3,552,000 | -104,000 | -247,000 | -40,000 |
| Financing Cash Flow | $-11,501,000 | $18,708,000 | $-14,396,000 | $-5,512,000 | $-3,928,000 |
| Exchange Rate Effect | -5,000 | 7,000 | -39,000 | 29,000 | -338,000 |
| Beginning Cash Position | 39,924,000 | 7,289,000 | 9,303,000 | 5,100,000 | 8,399,000 |
| End Cash Position | 8,449,000 | 39,924,000 | 7,289,000 | 9,303,000 | 5,100,000 |
| Net Cash Flow | $-31,475,000 | $32,635,000 | $-2,014,000 | $4,203,000 | $-3,299,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,588,000 | 13,324,000 | 13,427,000 | 9,960,000 | 7,041,000 |
| Capital Expenditure | -798,000 | -552,000 | -638,000 | -529,000 | -479,000 |
| Free Cash Flow | 16,790,000 | 12,772,000 | 12,789,000 | 9,431,000 | 6,562,000 |